Tresiba International Purchase Legalities: What You Need to Know in 2026

Is Importing Tresiba Technically Legal?

The short answer is no, but the FDA rarely acts against individual patients importing a 90-day supply for personal use. Federal law under the Food, Drug, and Cosmetic Act prohibits importing unapproved or non-FDA-approved versions of any drug, including insulin degludec. Tresiba manufactured in Canada or Europe is not FDA-approved, even if the molecule is identical. That legal gap matters.

The FDA Personal Importation Policy

The FDA published its personal importation guidance explicitly to acknowledge that strict enforcement against individual patients seeking affordable medication would cause undue hardship. The agency's current policy, maintained on its Import Basics page, allows case-by-case enforcement discretion when all of the following are true: the drug is for the patient's own personal use, the quantity does not exceed a 90-day supply, no commercialization or promotion is involved, and the drug does not present an unreasonable risk to the patient. [1]

This is discretion, not permission. The FDA can and does seize shipments that fall outside these parameters.

Why the Law Has Not Changed Despite Advocacy

Congress has debated drug importation bills for over two decades. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 included an importation provision, but the Secretary of Health and Human Services has never certified the program as safe, a requirement before the provision activates. [2] A 2020 FDA rule allowed state-level importation programs for certain drugs from Canada, but insulin was explicitly excluded from that rule's scope because insulin requires a separate biologics pathway under the Public Health Service Act. [3]

How the FDA Enforcement Discretion Policy Works in Practice

Customs and Border Protection (CBP) is the agency that physically intercepts international mail and courier shipments. CBP coordinates with the FDA when it finds pharmaceuticals. Under current joint guidance, CBP typically releases shipments meeting the personal-use criteria above without referring them to FDA for enforcement action. [1]

What Triggers a Seizure

Shipments are more likely to be seized when the quantity exceeds a 90-day supply, the package is addressed to a commercial entity, the pharmacy source appears on FDA's list of recalled or fraudulent foreign pharmacies, or the shipment lacks a valid U.S. Prescription. [1] Insulin is a prescription drug in all 50 states. California, Colorado, and a handful of other states passed laws allowing pharmacists to dispense short-term emergency insulin supplies without a prescription, but that state-level allowance does not affect federal importation requirements. [4]

Traveling With Tresiba Internationally

Traveling with your own supply is different from importing. The TSA allows insulin pens in carry-on bags without a 3-1-1 liquid restriction. The FDA advises travelers to carry the original pharmacy-labeled box and a copy of the prescription when crossing borders. [1] Tresiba's clinical stability profile supports this: an in-use pen remains stable at room temperature (below 30°C) for 56 days, longer than most insulin formulations, which simplifies travel logistics. [5]

Where Patients Actually Buy Tresiba Internationally

Licensed Canadian Online Pharmacies

Canada is the most common source for U.S. Patients seeking lower-cost Tresiba. Licensed Canadian pharmacies must be accredited by the Canadian International Pharmacy Association (CIPA) or the provincial regulatory body. CIPA's verified pharmacy list is publicly searchable. A box of Tresiba 100 units/mL FlexTouch pens (5 x 3 mL) retails for approximately $55, $80 CAD at CIPA-accredited pharmacies, versus a U.S. List price exceeding $530 USD. [6]

The supply chain in Canada routes through Health Canada-approved distributors. Novo Nordisk manufactures insulin degludec at its facility in Kalundborg, Denmark, for global distribution, so the molecule in a Canadian box is manufactured in the same facility as the U.S. Product. [5] The difference is regulatory approval pathway and pricing negotiation, not manufacturing origin.

Mexican Pharmacies (Farmacias)

Mexico allows over-the-counter purchase of many insulins without a prescription at farmacias. Prices run 60 to 80% below U.S. List. The risk is higher than Canada because the formal pharmacy accreditation infrastructure is less consistent. The FDA has issued specific warnings about substandard and counterfeit insulin products intercepted from Mexican sources, though those warnings have primarily targeted black-market channels rather than licensed farmacias. [7]

Telehealth-Facilitated International Access Programs

Some U.S.-based telehealth platforms partner with licensed Canadian or international mail-order pharmacies to support legal prescription transfer. These programs operate in a regulatory gray zone. The prescribing physician is U.S.-licensed, the dispensing pharmacy is foreign, and the product crosses an international border. The FDA's enforcement discretion policy technically applies, but patients should confirm that the telehealth platform has reviewed the compliance posture with legal counsel before enrolling. [1]

Counterfeit and Quality Risks With International Insulin

This is the part of the conversation that cost-comparison articles often skip. The WHO estimated in a 2017 study that 10.5% of medical products circulating in low-to-middle-income countries are substandard or falsified, with biologics including insulin among the highest-risk categories. [8] Canadian CIPA-accredited pharmacies represent a low-risk channel because the supply chain is federally regulated. Unlicensed online pharmacies, regardless of claimed country of origin, represent a substantially higher risk.

How to Verify a Foreign Pharmacy

Check for CIPA accreditation at cipa.com for Canadian sources. Look for a physical address and a licensed pharmacist contact. Avoid any site that sells without requiring a valid prescription. The FDA's BeSafeRx program maintains a database of known rogue internet pharmacies and provides a verification tool at fda.gov/besaferx. [7]

Cold Chain Integrity for Insulin

Insulin degludec, like all insulin products, requires refrigeration during shipping (2 to 8°C). Unsealed or improperly stored product can lose potency before it arrives. A study published in the journal Diabetes Care found that insulin exposed to temperatures above 37°C for more than 24 hours showed significant degradation in bioactivity. [9] When ordering internationally, request temperature-monitored shipping and inspect the package for cold pack integrity on arrival.

How to Get Tresiba Cheaper Without International Purchase

International importation is one cost-reduction strategy. Several U.S.-based options may achieve comparable or greater savings with lower legal and quality risk.

Novo Nordisk Patient Assistance Program

Novo Nordisk operates the Novo Nordisk Patient Assistance Program (PAP), which provides free Tresiba to uninsured or underinsured patients meeting income criteria. The income threshold for the PAP is generally set at or below 400% of the federal poverty level, though Novo Nordisk reserves the right to adjust criteria. Applications are available directly at novonordiskus.com. Patients already enrolled in Medicare Part D are typically ineligible for manufacturer PAPs under federal anti-kickback rules, but may qualify for Extra Help (Low Income Subsidy). [10]

The $35 Insulin Cap Under the IRA

The Inflation Reduction Act of 2022 capped out-of-pocket costs for covered insulin products at $35 per month for Medicare Part D enrollees, effective January 1, 2023. This cap applies to insulin degludec (Tresiba) when it appears on a Part D formulary. [11] For commercially insured patients, many insurers voluntarily adopted a $35 cap following political pressure, but it is not federally required for private insurance. Verify your specific plan's formulary tier for Tresiba before assuming the cap applies.

GoodRx, Mark Cuban's Cost Plus Drugs, and Manufacturer Coupons

GoodRx lists Tresiba at $250, $420 per box at major U.S. Retail pharmacies depending on location, which is below list price but still high for patients without insurance. Cost Plus Drugs (costplusdrugs.com), founded by Mark Cuban, does not currently carry Tresiba because Novo Nordisk has not agreed to Cost Plus pricing terms for branded insulin. [12] Novo Nordisk's own savings card (Novo Nordisk Savings Card) provides eligible commercially insured patients up to $99/month off out-of-pocket costs. Eligibility excludes government-program beneficiaries. [10]

Formulary Alternatives to Tresiba

If cost is the barrier, a formulary-preferred basal insulin may be clinically equivalent for many patients. The BRIGHT trial (N=929) compared insulin degludec (Tresiba) to insulin glargine 300 units/mL (Toujeo) and found non-inferior HbA1c reductions at 24 weeks, with comparable rates of hypoglycemia. [13] Insulin glargine 100 units/mL (Basaglar, a biosimilar) is available at substantially lower cost on many formularies. The ADA 2025 Standards of Care state: "When initiating basal insulin, choice among available basal insulins should be individualized based on the patient's risk of hypoglycemia, cost, and formulary access." [14]

HSA and FSA Use for Tresiba

Insulin is explicitly listed as a qualified medical expense under IRS Publication 502, making Tresiba purchases eligible for payment with Health Savings Account (HSA) or Flexible Spending Account (FSA) funds. [15] This applies to U.S.-dispensed Tresiba purchased at a licensed U.S. Pharmacy with a valid prescription.

Does HSA/FSA Apply to International Purchases?

The IRS does not distinguish between U.S. And foreign pharmacies when defining qualified medical expenses for HSA/FSA purposes, provided the drug is legally obtained and used for a legitimate medical purpose. [15] However, many HSA/FSA administrators (the banks or third-party administrators that issue the debit cards) will decline transactions at foreign merchants because the merchant category code (MCC) may not match the expected pharmacy MCC, or the foreign pharmacy may not have the correct MCC configured. Reimbursement by submitting a receipt after the fact is typically allowed, but you should confirm this with your specific HSA/FSA administrator before ordering internationally. [15]

Documenting Insulin Purchases for Tax Purposes

Keep the original invoice from the foreign pharmacy, your valid U.S. Prescription, and proof of payment. If audited, the IRS will want documentation that the expense was for insulin (a qualified expense) and for the taxpayer or a qualified dependent. Purchases for resale or for persons not on your tax return are not eligible. [15]

Insulin Degludec: Clinical Background Relevant to Access Decisions

Understanding why Tresiba is prescribed helps patients advocate for themselves in coverage conversations.

Pharmacology and Duration of Action

Insulin degludec forms multi-hexamer chains in subcutaneous tissue after injection, creating a depot that releases insulin monomers slowly over more than 42 hours. This produces a flat, stable pharmacokinetic profile with a duration of action exceeding 42 hours in most patients. [5] The clinical consequence is a lower coefficient of variation in day-to-day glucose-lowering effect compared to insulin glargine 100 units/mL, which may translate to lower hypoglycemia risk. The BEGIN Basal-Bolus Type 1 trial (N=629) found that insulin degludec reduced nocturnal confirmed hypoglycemia by 25% versus insulin glargine 100 units/mL (P<0.001) in adults with type 1 diabetes over 52 weeks. [16]

Approved Indications and Dosing Flexibility

The FDA approved Tresiba (NDA 203314) in September 2015 for adults with type 1 and type 2 diabetes, and subsequently approved use in children age 1 year and older. [17] A clinically important feature is dosing flexibility: the prescribing information states that Tresiba can be dosed at any time of day, and the interval between injections can range from 8 to 40 hours without meaningfully affecting glycemic control. [5] This flexibility is relevant to international travelers adjusting to time zone changes.

Cardiovascular Safety

The DEVOTE trial (N=7,637) compared insulin degludec to insulin glargine 100 units/mL in patients with type 2 diabetes at high cardiovascular risk. Degludec was non-inferior to glargine for the composite MACE endpoint (3-point MACE: cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) over a median follow-up of 2 years. [18] The trial also found a 40% reduction in severe hypoglycemia episodes with degludec versus glargine (rate ratio 0.60, P<0.001), an important secondary finding. [18]

Practical Step-by-Step: Getting Tresiba at a Lower Cost Legally

1. Contact your insurer's pharmacy benefits line and ask for the current tier and out-of-pocket cost for Tresiba under your specific plan. Ask whether a prior authorization is required.
2. Ask your prescriber whether a biosimilar basal insulin (Basaglar, Semglee, or Rezvoglar) is clinically appropriate. The ADA 2025 Standards affirm biosimilar insulins as acceptable alternatives when cost is a barrier. [14]
3. Apply for the Novo Nordisk PAP or Savings Card at novonordisk-us.com if you are uninsured or commercially insured with high cost-sharing.
4. If Medicare Part D, verify that Tresiba is on your plan's formulary and confirm the $35/month IRA cap applies. [11]
5. If considering a Canadian pharmacy, use only CIPA-verified pharmacies. Bring your U.S. Prescription. Order no more than a 90-day supply. Use temperature-monitored shipping.
6. Pay with your HSA/FSA debit card or save your receipt for reimbursement. Retain documentation for potential IRS review. [15]